• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Red blood cell deformability and secondary hyperparathyroidism in uremic patients on maintenance hemodialysis.

作者信息

Docci D, Turci F, Salvi P, Pretolani E

出版信息

Artif Organs. 1984 May;8(2):141-4. doi: 10.1111/j.1525-1594.1984.tb04262.x.

DOI:10.1111/j.1525-1594.1984.tb04262.x
PMID:6547327
Abstract

The possible relationship between red blood cell (RBC) deformability and secondary hyperparathyroidism (HPT) in 23 patients on maintenance hemodialysis was examined. Secondary HPT was evaluated by means of serum biochemistry (parathyroid hormone, calcium, phosphorus, and alkaline phosphatase) and radiographic examinations. This study showed that RBC deformability is markedly reduced in hemodialyzed patients when compared with normal controls. No significant correlation between RBC deformability and the hematochemical changes associated with secondary HPT was found. No difference in RBC deformability was observed as far as the activity (alkaline phosphatase) and the severity (radiographic findings) of secondary HPT are concerned. Effective treatment of secondary HPT by either pharmacological means (1 alpha, 25-dihydroxycholecalciferol therapy) or surgical removal was not associated with consequent improvement in RBC deformability. It is concluded that secondary HPT is probably not a major factor influencing RBC deformability in uremic patients on maintenance hemodialysis.

摘要

相似文献

1
Red blood cell deformability and secondary hyperparathyroidism in uremic patients on maintenance hemodialysis.
Artif Organs. 1984 May;8(2):141-4. doi: 10.1111/j.1525-1594.1984.tb04262.x.
2
Osmotic fragility of erythrocytes, cell deformability and secondary hyperparathyroidism in uremic patients on maintenance hemodialysis.维持性血液透析的尿毒症患者红细胞的渗透脆性、细胞变形性及继发性甲状旁腺功能亢进
Clin Nephrol. 1985 Feb;23(2):68-73.
3
Lack of relation between secondary hyperparathyroidism and red blood cell osmotic fragility in chronic renal failure.慢性肾衰竭患者继发性甲状旁腺功能亢进与红细胞渗透脆性之间缺乏相关性。
Nephron. 1985;41(3):241-5. doi: 10.1159/000183590.
4
Lack of evidence for the role of secondary hyperparathyroidism in the pathogenesis of uremic thrombocytopathy.继发性甲状旁腺功能亢进在尿毒症血小板病发病机制中的作用缺乏证据。
Nephron. 1986;43(1):28-32. doi: 10.1159/000183713.
5
Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis.静脉注射1-α-羟维生素D3对维持性血液透析慢性尿毒症患者继发性甲状旁腺功能亢进的影响。
Nephron. 1989;53(3):194-200. doi: 10.1159/000185744.
6
Pregnant Patient on Hemodialysis Who Showed Remarkable Improvement of Severe Hyperparathyroidism by Strict Serum Phosphorus Control.通过严格控制血清磷使严重甲状旁腺功能亢进显著改善的血液透析妊娠患者。
Intern Med. 2020 Mar 1;59(5):689-694. doi: 10.2169/internalmedicine.3774-19. Epub 2019 Nov 18.
7
The effect of peroral calcitriol in small doses on mild secondary hyperparathyroidism in patients on hemodialysis.小剂量口服骨化三醇对血液透析患者轻度继发性甲状旁腺功能亢进的影响。
Am J Nephrol. 1995;15(5):401-6. doi: 10.1159/000168873.
8
Effects of dietary phosphorus restriction on secondary hyperparathyroidism in hemodialysis patients during intermittent oral high-dose 1,25(OH)2D3 treatment.
J Nutr Sci Vitaminol (Tokyo). 1991 Dec;37 Suppl:S105-12. doi: 10.3177/jnsv.37.supplement_s105.
9
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
10
Secondary hyperparathyroidism in patients on maintenance hemodialysis: study of the N and C-terminal parathyroid hormones.维持性血液透析患者的继发性甲状旁腺功能亢进:N端和C端甲状旁腺激素的研究
Tokai J Exp Clin Med. 1983 Jul;8(3):225-8.